The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection

Sponsor
Sisli Hamidiye Etfal Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04874363
Collaborator
(none)
150
1
2.5
60.1

Study Details

Study Description

Brief Summary

This is a retrospective single centered study that was done in the ICU on patients with Covid-19 between 16th of March -16th of May in 2020 Retrospective records will be examined by examining the electronic data files of the patients.

There were two groups as smoker and non-smoker.

Condition or Disease Intervention/Treatment Phase
  • Other: no intervention

Detailed Description

The aims of the present study is to see the effects of smoking prevalence, the length of stay regarding the usage of cigarettes, and the effects on the mortality of COVID-19 in our intensive care unit(ICU).

This is a retrospective single centered study that was done in the ICU on patients with Covid-19 between 16th of March -16th of May in 2020. The demographic data, comorbidity status, the units they were accepted from, clinical symptoms , respiratory support, prevalence of smoking, length of stay in the ICU and mortalities of the patients weill be recorded. There are two groups as smoker and non-smoker.

Study Design

Study Type:
Observational
Actual Enrollment :
150 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
The Effects of Smoking on Mortality in Intensive Care Unit in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection
Actual Study Start Date :
Mar 15, 2020
Actual Primary Completion Date :
May 15, 2020
Actual Study Completion Date :
May 30, 2020

Arms and Interventions

Arm Intervention/Treatment
smoker

active smokers

Other: no intervention
no intervention

non-smoker

Patients who have never smoked

Other: no intervention
no intervention

Outcome Measures

Primary Outcome Measures

  1. Mortality [3 months]

    Mortality rates of patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All the patient's data are diagnosed with acute respiratory syndrome Covid-19 over 18 years old
Exclusion Criteria:
  • Patients under 18 years of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sisli Hamidiye Etfal Research and Training Hospital Istanbul Turkey

Sponsors and Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Seyhan Metin, medical doctor, Sisli Hamidiye Etfal Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04874363
Other Study ID Numbers:
  • 2810
First Posted:
May 5, 2021
Last Update Posted:
May 5, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2021